
PartnershipNov 17, 2026, 09:06 AM
Myriad Genetics Expands Japan Collaboration with SRL for Local Testing
AI Summary
Myriad Genetics, Inc. is expanding its collaboration with SRL, a leading Japanese clinical laboratory testing company, to enable local testing for its BRACAnalysis® Diagnostic System in Japan. This expansion, subject to regulatory approval, aims to improve patient and healthcare provider experiences by reducing sample shipping times and increasing testing efficiency. The partnership is expected to establish local capabilities for future Myriad offerings and long-term growth in the Japanese market.
Key Highlights
- Myriad Genetics expands collaboration with SRL to enable local BRACAnalysis® Diagnostic System testing in Japan.
- Local testing is expected to improve testing efficiency and shorten sample turn-around-time.
- The collaboration aims to establish local capabilities for future Myriad offerings and long-term growth in Japan.
- SRL will perform laboratory wet work locally, while Myriad will provide genetic interpretation services.
- Myriad intends to pursue additional regulatory approvals and reimbursement in Japan.
Price Impact
More from MYGN